GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adlai Nortye Ltd (NAS:ANL) » Definitions » Price-to-Free-Cash-Flow

ANL (Adlai Nortye) Price-to-Free-Cash-Flow : N/A (As of Sep. 28, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Adlai Nortye Price-to-Free-Cash-Flow?

As of today (2024-09-28), Adlai Nortye's share price is $2.0652. Adlai Nortye's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.50. Hence, Adlai Nortye's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Adlai Nortye's Price-to-Free-Cash-Flow or its related term are showing as below:

ANL's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 37.4
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Adlai Nortye's Free Cash Flow per Share for the three months ended in Jun. 2024 was $0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.50.


Adlai Nortye Price-to-Free-Cash-Flow Historical Data

The historical data trend for Adlai Nortye's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adlai Nortye Price-to-Free-Cash-Flow Chart

Adlai Nortye Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - -

Adlai Nortye Quarterly Data
Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Dec23 Jun24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Adlai Nortye's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Adlai Nortye's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adlai Nortye's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adlai Nortye's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Adlai Nortye's Price-to-Free-Cash-Flow falls into.



Adlai Nortye Price-to-Free-Cash-Flow Calculation

Adlai Nortye's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=2.0652/-0.496
=N/A

Adlai Nortye's Share Price of today is $2.0652.
Adlai Nortye's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.50.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Adlai Nortye  (NAS:ANL) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Adlai Nortye Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Adlai Nortye's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Adlai Nortye Business Description

Traded in Other Exchanges
N/A
Address
685 US Highway 1, New Jersey Biotechnology Development Center, 2nd floor, North Brunswick, NJ, USA, 08902
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.